The store will not work correctly when cookies are disabled.
2-(3-chloropyridin-4-yl)-N-propylpyrido[3,4-d]pyrimidin-4-amine
ID: ALA4525661
PubChem CID: 145744617
Max Phase: Preclinical
Molecular Formula: C15H14ClN5
Molecular Weight: 299.77
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCNc1nc(-c2ccncc2Cl)nc2cnccc12
Standard InChI: InChI=1S/C15H14ClN5/c1-2-5-19-14-11-4-7-18-9-13(11)20-15(21-14)10-3-6-17-8-12(10)16/h3-4,6-9H,2,5H2,1H3,(H,19,20,21)
Standard InChI Key: AXRIGFZUVQRHPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
16.9629 -9.8888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9487 -12.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2553 -12.7545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5331 -12.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5331 -11.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2553 -11.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9487 -11.5411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2553 -10.2988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8438 -11.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1216 -11.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1216 -12.3500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8438 -12.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6710 -12.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3644 -13.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6710 -13.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9617 -9.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0866 -13.5923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3644 -12.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0859 -12.7471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9624 -13.9993 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.6688 -8.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
6 8 1 0
5 9 1 0
9 10 2 0
10 11 1 0
12 11 2 0
4 12 1 0
2 13 1 0
18 13 2 0
14 17 1 0
15 14 2 0
13 15 1 0
8 1 1 0
1 16 1 0
19 17 2 0
18 19 1 0
15 20 1 0
16 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.77 | Molecular Weight (Monoisotopic): 299.0938 | AlogP: 3.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.59 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.36 | CX LogP: 2.91 | CX LogD: 2.91 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -1.34 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |